-
First Person
To Test or Not to TestTwenty-two years after the first of two breast cancer diagnoses, a survivor decides to undergo genetic testing.
by Cynthia Ryan
-
The Work-Cancer Balance
Some patients want to work through illness and others need to, but juggling work responsibilities and treatment regimens can be a challenge.
by Leigh Labrie
-
Healthy Habits
Pile on the VeggiesA study evaluates whether a change in diet could slow prostate cancer growth.
by Melinda Mahaffey Icden
-
Q&A
Conversation StarterCancer survivor Emily McDowell creates greeting cards that give people the words to talk about a difficult disease.
by Stephen Ornes
-
Forward Look
An Rx for ExercisePatients benefit when oncologists encourage physical activity.
by Brenda Conaway
-
Forward Look
Childhood Cancer Survivors at Risk for Hormone DeficienciesNew study highlights importance of survivorship care.
by Sharon Reynolds
-
Sound Advice
Fall 2015vol 05 | issue 03
Coping with weight gain while being treated, telling family and friends how you feel, and supporting parents who are used to taking care of themselves. -
Forward Look
Tuning In to the Concerns of CaregiversAfter a death, caregivers may need their own support.
by Marilyn Fenichel
-
Preserving the Future
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff